The Scientist

» FDA and ecology

Most Recent

image: Disclosure of Problematic Scopes Delayed: Report

Disclosure of Problematic Scopes Delayed: Report

By | January 14, 2016

The US Senate has found hospitals, a device maker, and federal regulators dragged their feet on reporting contaminated endoscopes.

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Diagnostics Group Refutes FDA’s Concerns

Diagnostics Group Refutes FDA’s Concerns

By | December 17, 2015

The Association for Molecular Pathology finds fault in the agency’s report on safety issues associated with certain lab tests.

0 Comments

image: Drug Produced in GM Chicken Approved

Drug Produced in GM Chicken Approved

By | December 10, 2015

The US Food and Drug Administration greenlights a rare-disease drug that is produced in the eggs of genetically modified chickens.

1 Comment

image: Owl Be Darned

Owl Be Darned

By | December 4, 2015

Researchers studying city-dwelling birds are learning about which animals are more suited to urban life.

1 Comment

image: A Rainforest Chorus

A Rainforest Chorus

By | December 1, 2015

Researchers measure the health of Papua New Guinea’s forests by analyzing the ecological soundscape.

0 Comments

image: Jungle Field Trip

Jungle Field Trip

By | December 1, 2015

Travel to remote rain forests in Papua New Guinea with researchers from The Nature Conservancy who are working with native people to characterize ecosystems there using sound.

0 Comments

image: Urban Owl-Fitters

Urban Owl-Fitters

By | December 1, 2015

How birds with an innate propensity for living among humans are establishing populations in cities

0 Comments

image: Spiders, Prey Leave DNA

Spiders, Prey Leave DNA

By | November 30, 2015

A study of black widow spiders suggests that the arachnids leave traces of their own genetic material and DNA from prey in their sticky webs.

0 Comments

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

Popular Now

  1. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  2. Gut Microbes Linked to Neurodegenerative Disease
  3. Pubic Hair Grooming Linked to STI Risk
    The Nutshell Pubic Hair Grooming Linked to STI Risk

    Observational study suggests pubic hair grooming correlates with heightened risk of acquiring sexually transmitted infections, although causation remains unclear.

  4. Naive T Cells Find Homes in Lymphoid Tissue
Rockland